These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26204705)

  • 1. Transfusion Solution.
    Haelle T
    Sci Am; 2015 Jul; 313(1):20. PubMed ID: 26204705
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood safety in Mexico. Achievements and challenges].
    Sánchez-Guerrero SA
    Rev Invest Clin; 2011; 63(3):309-13. PubMed ID: 21888294
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood & politics.
    Titus K
    CAP Today; 1996 Mar; 10(3):20, 22-4. PubMed ID: 10160264
    [No Abstract]   [Full Text] [Related]  

  • 4. AABB contributions to plasma safety.
    Triulzi DJ
    Transfusion; 2012 May; 52 Suppl 1():5S-8S. PubMed ID: 22578373
    [No Abstract]   [Full Text] [Related]  

  • 5. Revisions to the requirements applicable to blood, blood components, and source plasma. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Aug; 66(151):40886-90. PubMed ID: 11732557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter on Bacterial contamination in platelet concentrates.
    Harm SK; Delaney M; Aubuchon JP; Triulzi DJ; Yazer MH
    Vox Sang; 2014 Oct; 107(3):312. PubMed ID: 25040131
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings of a consensus conference: Risk-Based Decision Making for Blood Safety.
    Leach Bennett J; Blajchman MA; Delage G; Fearon M; Devine D
    Transfus Med Rev; 2011 Oct; 25(4):267-92. PubMed ID: 21763103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trans people and blood donation.
    Goldman M; Butler-Foster T; Lapierre D; O'Brien SF; Devor A
    Transfusion; 2020 May; 60(5):1084-1092. PubMed ID: 32343438
    [No Abstract]   [Full Text] [Related]  

  • 9. Repeat voluntary non-remunerated blood donor is the best quality indicator for blood safety.
    Nair SC; Mammen JJ
    Indian J Med Res; 2015 Jun; 141(6):749-52. PubMed ID: 26205016
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood investigation.
    AIDS Policy Law; 1996 May; 11(9):12. PubMed ID: 11363471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS and the blood supply: an analysis of law, regulation, and public policy.
    Salbu SR
    Wash Univ Law Q; 1996; 74(4):913-80. PubMed ID: 16273697
    [No Abstract]   [Full Text] [Related]  

  • 12. Transfusion-related acute lung injury (TRALI): A Canadian blood services research and development symposium.
    Saidenberg E; Petraszko T; Semple E; Branch DR
    Transfus Med Rev; 2010 Oct; 24(4):305-24. PubMed ID: 20851333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of predonation screening for transfusion transmissible infections using rapid test kits in a hospital-based blood transfusion centre.
    Dosunmu AO; Akinbami AA; Ismail AK; Olaiya MA; Uche EI; Aile IK
    Niger Postgrad Med J; 2017; 24(3):162-167. PubMed ID: 29082905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety improving by complementary serological and molecular testing combined with pathogen reduction of the donated blood in window period.
    Balint B; Vucetic D; Todorovic-Balint M; Borovcanin N; Jovanovic-Cupic S; Mandusic V
    Transfus Apher Sci; 2013 Aug; 49(1):103-4. PubMed ID: 23820432
    [No Abstract]   [Full Text] [Related]  

  • 15. [Seventeen years of haemovigilance in France: assessment and outlook].
    Carlier M; Vo Mai MP; Fauveau L; Ounnoughene N; Sandid I; Renaudier P
    Transfus Clin Biol; 2011 Apr; 18(2):140-50. PubMed ID: 21474356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Legal and regulatory problems facing blood suppliers.
    Sazama K
    Healthspan; 1989 Sep; 6(8):8-14. PubMed ID: 10295543
    [No Abstract]   [Full Text] [Related]  

  • 17. Revisiting Factor VIII cases: is it time for an agency adjudication system?
    Su YC
    Food Drug Law J; 2008; 63(4):943-61. PubMed ID: 19601390
    [No Abstract]   [Full Text] [Related]  

  • 18. Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop.
    Gallagher LM; Ganz PR; Yang H; Kessler DA; O'Brien SF; Custer BS; Busch MP; Dodd RY; Stramer SL; Walderhaug MO; Forshee RA; Williams AE; Epstein JS; Anderson SA
    Transfusion; 2013 Feb; 53(2):455-63. PubMed ID: 22845334
    [No Abstract]   [Full Text] [Related]  

  • 19. Current good manufacturing practices for transfusion medicine.
    Sazama K
    Transfus Med Rev; 1996 Oct; 10(4):286-95. PubMed ID: 8899957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Develop a useful donor-screening process.
    Harty-Golder B
    MLO Med Lab Obs; 2003 Oct; 35(10):34. PubMed ID: 14571850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.